Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2025-04-11 00:00:00 ET · period of report 2025-04-11 · accession 0000897069-25-000789 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-11 | 2025-04-01 | PCSA | Bigora Sian | Chief Development Off | F - Tax | $0.41 | -3,311 | 33.6K | -9% | -$1,358 | |
| 2025-04-11 | 2025-04-01 | PCSA | Bigora Sian | Chief Development Off | M - OptEx | — | +15.1K | 36.9K | +69% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | F | D | 3,311 | $0.41 | 33,626 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-01 | M | A | 15,059 | — | 36,937 | D | — | — | (F1) Distribution of vested restricted shares. |